T-cell subsets, IFN-γ production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells
- 15 October 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (4) , 653-657
- https://doi.org/10.1002/ijc.2910460417
Abstract
In addition to previous evidence for a role of L3T4+ T cells in the protective anti‐parental tumor immunity induced by xenogenized variant cells of a murine lymphoma (L5I78Y/DTIC), we have investigated the possible participation in this effect of L5I78Y tumor‐specific lymphocytes of the Lyt‐2+ T cell subset. Spleen cells from L5178Y/DTIC tumor‐immunized mice produced high levels of IFN‐γ in vitro in response to parental antigens, and this activity was only abolished by treating the responder population with anti‐Thy‐1.2 antibody or a combination of anti‐L3T4 and anti‐Lyt‐2.2 monoclonal antibodies (MAbs) plus complement. Positively selected L3T4+ and Lyt‐2+ cells also produced IFN‐γ in vitro, provided accessory cells (plastic‐adherent and Thy‐I− Ia− splenocytes, respectively) were added to the lymphocyte‐tumor cell co‐cultures. The production of IFN‐γ by purified L3T4+ and Lyt‐2+ cells was inhibited by addition of the respective anti‐class‐II and anti‐class‐I H‐2 antibody to the cultures. Administration of anti‐IFN‐γ MAb in vivo significantly impaired the resistance of L5178Y/DTIC‐immune mice to challenge with parental cells, as manifested by survival criteria and increased tumor‐cell proliferation in the spleens of antibody‐treated mice. Although anti‐parental tumor protection in vivo and T‐cell activation in vitro for IFN‐γ production were strictly antigen‐specific, bystander tumor inhibition was observed when antigenically irrelevant cells were inoculated with the L5178Y lymphoma. These results suggest that both L3T4+ and Lyt‐2+ T cells play a role in the protective anti‐parental tumor immunity induced by xenogenized cells, and that their activity may involve IFN‐γ‐mediated stimulation of non‐specific tumoricidal mechanisms.This publication has 16 references indexed in Scilit:
- Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: Relationship to MuLV gp70European Journal of Immunology, 1990
- Cell-mediated immunity to chemically xenogenized tumors — IV. Production of lymphokine activity by, and in response to, highly immunogenic cellsInternational Journal of Immunopharmacology, 1989
- Heterogeneity of Cytokine Secretion Patterns and Functions of Helper T CellsPublished by Elsevier ,1989
- Induction of tumor suppression and delayed‐type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variantInternational Journal of Cancer, 1988
- Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variantInternational Journal of Cancer, 1987
- Chemical xenogenization of experimental tumorsCancer and Metastasis Reviews, 1987
- Humoral response against murine lymphoma cells xenogenized by drug treatment in vivoInternational Journal of Cancer, 1985
- Antigenic Tumor Cell Variants Obtained with MutagensAdvances in Cancer Research, 1983
- Growth Inhibition of Normal or Drug-Treated Lymphoma Cells in Lethally Irradiated Mice2JNCI Journal of the National Cancer Institute, 1978
- IMMUNOLOGICAL ALTERNATION OF LEUKEMIC CELLS In Vivo AFTER TREATMENT WITH AN ANTITUMOR DRUGProceedings of the National Academy of Sciences, 1970